Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer

The diagnosis of prostate cancer is based on histology. Prostate biopsies are obtained based on the triad of prostate specific antigen (PSA), digital rectal examination (DRE) and transrectal ultrasound. Because prostate biopsies still have a large percentage of negative outcomes, patient selection and biopsy direction need improvement. This paper describes the recent improvements in prostate cancer imaging, especially contrast-enhanced transrectal ultrasound.

[1]  J. Pruim,et al.  Visualization of prostate cancer with 11C-choline positron emission tomography. , 2002, European urology.

[2]  P. Phillips,et al.  Contrast–agent detection and quantification , 2004, European radiology.

[3]  G. Bartsch,et al.  Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. , 2005, The Journal of urology.

[4]  F Tranquart,et al.  Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue , 2004, European radiology.

[5]  F. Frauscher,et al.  Prostate: high-frequency Doppler US imaging for cancer detection. , 2002, Radiology.

[6]  Freddie C Hamdy,et al.  Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. , 2005, European urology.

[7]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[8]  I. Derweesh,et al.  Continuing trends in pathological stage migration in radical prostatectomy specimens. , 2004, Urologic oncology.

[9]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.

[10]  Vladimir Bilim,et al.  Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is a useful modality for the precise detection and staging of early prostate cancer , 2005, The Prostate.

[11]  T. Shankey,et al.  Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. , 1996, Urology.

[12]  Hessel Wijkstra,et al.  Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer , 2001, European Urology.

[13]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[14]  H. Levin,et al.  Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Visser,et al.  Microbubbles and ultrasound: from diagnosis to therapy. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[16]  W. Catalona,et al.  Interexaminer variability of digital rectal examination in detecting prostate cancer. , 1995, Urology.

[17]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[18]  M. Blake,et al.  Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. , 2001, Radiology.

[19]  C. Dinney,et al.  Diagnostic testing for prostate cancer detection: less is best. , 1993, Urology.

[20]  Nico de Jong,et al.  Basic Acoustic Properties of Microbubbles , 2002, Echocardiography.

[21]  T. Scheenen,et al.  Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. , 2006, Radiology.

[22]  Xavier Buy,et al.  Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. , 2003, The Journal of urology.

[23]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[24]  Hessel Wijkstra,et al.  The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. , 2003, European urology.

[25]  Ferdinand Frauscher,et al.  Detection of prostate carcinoma with contrast‐enhanced sonography using intermittent harmonic imaging , 2005, Cancer.

[26]  Mario Marengo,et al.  Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  S. Loening,et al.  Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99. , 2005, European urology.

[28]  J. McKiernan,et al.  PSA updated: still relevant in the new millennium? , 2005, European urology.

[29]  J. Habbema,et al.  Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam) , 1999, International journal of cancer.

[30]  C C Schulman,et al.  Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. , 2000, The Journal of urology.

[31]  M. Wildhagen,et al.  The value of current diagnostic tests in prostate cancer screening , 2001, BJU international.

[32]  R G Aarnink,et al.  Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. , 1999, Urology.

[33]  A. Lim,et al.  Functional studies , 2004, European radiology.

[34]  William R Wagner,et al.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. , 2005, Cancer research.

[35]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[36]  Ian M Thompson,et al.  Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker , 2004, Cancer.

[37]  E. Halpern,et al.  Prostate cancer: contrast-enhanced us for detection. , 2001, Radiology.

[38]  F. Taşkın,et al.  The value of contrast enhanced power Doppler ultrasonography in differentiating hypoehoic lesions in the peripheral zone of prostate. , 2005, European journal of radiology.

[39]  Georg Bartsch,et al.  Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. , 2002, The Journal of urology.

[40]  R Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[41]  J. Pruim,et al.  11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. , 2003, European urology.

[42]  Jan Lehmann,et al.  Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions , 2004, World Journal of Urology.

[43]  F. Aragona,et al.  Does the adjunct of ecographic contrast medium Levovist® improve the detection rate of prostate cancer? , 2003, Prostate Cancer and Prostatic Diseases.

[44]  G. V. von Schulthess,et al.  Fluorocholine PET/CT in patients with prostate cancer: initial experience. , 2005, Radiology.

[45]  T. Loch,et al.  [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer]. , 2004, Der Urologe. Ausg. A.

[46]  Hessel Wijkstra,et al.  Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma , 2002, The Prostate.

[47]  R G Aarnink,et al.  Three‐dimensional contrast‐enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer , 2000, BJU international.

[48]  L. Holmberg,et al.  The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. , 1997, Urology.

[49]  M. Terris,et al.  Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. , 2001, Urology.

[50]  S. Bigler,et al.  Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. , 2000, The Journal of urology.

[51]  Jiri Sklenar,et al.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. , 2003, Circulation.

[52]  Ryuichi Morishita,et al.  An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney , 2005, The journal of gene medicine.

[53]  Hessel Wijkstra,et al.  The Application of Three–Dimensional Contrast–Enhanced Ultrasound to Measure Volume of Affected Tissue after HIFU Treatment for Localized Prostate Cancer , 2000, European Urology.

[54]  A. Nilsson.  Contrast–enhanced ultrasound of the kidneys , 2004, European radiology.

[55]  Z. Hall.  Cancer , 1906, The Hospital.

[56]  Susanne Hempel,et al.  Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.

[57]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.